NHI Q3 Normalized FFO $1.08; revises 2023 guidance; occupancy improves

NATIONAL HEALTH INVESTORS INC

2023-Q3 EPS reported $2.39 revenue$240,370,000

Net income per diluted share $0.68 (Q3 2023) vs $0.78 prior year; Normalized FFO $1.08 vs $1.06.
Revised 2023 Normalized FFO guidance to $4.28-$4.31 (from $4.31-$4.35); Normalized FAD raised to $186M-$187.6M.
Occupancy improved: Bickford 84.8% (Sep vs 84.7% prior year), SHOP 81.2% (vs 76.6%).
Net debt/EBITDA 4.4x; $205M drawn on $700M revolver; $50M private notes repaid.
Portfolio: $25M mezzanine loan amended at 10%; sold three ALFs for $5.4M cash plus $1.6M financing.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

NATIONAL HEALTH INVESTORS INC reported the three and nine months ended September 30, 2023 results: net income Net income attributable to common stockholders per diluted common share for the three months ended September 30, 2023 wa, EPS $0.68. Guidance lowered.

Period: the three and nine months ended September 30, 2023
Net income: Net income attributable to common stockholders per diluted common share for the three months ended September 30, 2023 wa
EPS: $0.68
Guidance: lowered
Result: reported results

Exact text from the filing

NHI Announces Third Quarter 2023 Results MURFREESBORO, Tenn. – (November 7, 2023) National Health Investors, Inc. (NYSE:NHI) announced today its results for the three and nine months ended September 30, 2023.

View on SEC.gov

Browse all earnings releases →

NATIONAL HEALTH INVESTORS INC filing history →

Source: SEC EDGAR

accession 0000877860-23-000110

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.